COLOSTRUM MARKET ANALYSIS

Key Developments

• In April 2024, Goodhealth New Zealand Limited launched a new line of organic bovine colostrum powder, catering to the growing demand for health-conscious consumers seeking natural and sustainable options. Bovine colostrum, the first milk produced by cows after giving birth, is rich in immune-boosting properties and has been used for centuries to support overall health and well-being.
• In January 2023, NutraScience Labs expanded its product range by introducing new colostrum capsules designed to support immune health. Bovine colostrum, known for its rich content of antibodies, growth factors, and nutrients, is recognized for its potential to enhance the immune system and promote overall well-being.
• In July 2023, ImmuCell Corporation, a biotechnology company specializing in the development of immunoglobulin-based products for both veterinary and human health, announced a partnership with a research institution to explore new pharmaceutical applications for colostrum. This collaboration aims to harness the unique properties of colostrum, which is rich in immunoglobulins and growth factors, to create innovative therapeutic solutions. By combining ImmuCell's expertise in biotechnology with the research institution's resources, the partnership seeks to unlock the potential of colostrum in various health applications, reinforcing ImmuCell's commitment to advancing health outcomes through scientific innovation.
• In March 2021, Biostrum Nutritech announced the acquisition of a new facility to increase its colostrum processing capacity. This strategic move aligns with the company's goal of meeting the growing demand for its colostrum products while maintaining its high standards of quality and consistency.